Prosecution Of Counterfeit Pharmaceutical Production
1. Vishwas Udupa vs. Union of India, 2006 (India)
Court: Karnataka High Court
Key Issue: Manufacturing and selling counterfeit medicines
Facts:
The accused, Vishwas Udupa, was found producing tablets that were labeled as a reputed brand but contained substandard ingredients. The medicines were sold across Karnataka.
Court Decision:
The court held that production and distribution of counterfeit medicines violates the Drugs and Cosmetics Act, 1940, and Indian Penal Code (IPC) Sections 420, 272, and 273 (cheating and adulteration).
Conviction included imprisonment and fines, and the counterfeit products were confiscated.
Significance:
Reinforced that public health is a critical concern, and counterfeit pharmaceuticals carry criminal liability.
Established precedence for prosecuting manufacturers of substandard medicines.
2. Union of India vs. Dinesh Kumar & Ors., 2008
Court: Delhi High Court
Key Issue: Sale of counterfeit antibiotics
Facts:
The defendants were caught selling antibiotics labeled as a licensed product, but the contents were either ineffective or harmful. The investigation revealed fraudulent labeling and intentional misrepresentation.
Court Decision:
Court convicted the accused under Sections 420 (cheating), 272 & 273 (adulteration of drugs) of IPC, and Section 27 of the Drugs and Cosmetics Act.
The defendants were sentenced to rigorous imprisonment and fined, emphasizing criminal liability for counterfeit production.
Significance:
Highlighted that both manufacturing and distribution of counterfeit drugs are prosecutable offenses.
Emphasized consumer protection and public safety as a judicial priority.
3. United States v. Liew, 2011 (US Case)
Court: United States District Court, California
Key Issue: Counterfeit oncology drugs
Facts:
Liew and his associates imported and distributed counterfeit cancer drugs, claiming them to be legitimate and safe. Many patients were exposed to substandard and potentially toxic medicines.
Court Decision:
Convicted under 18 U.S.C. § 2320 (trafficking in counterfeit goods) and 18 U.S.C. § 1341 (mail fraud).
Liew received 20 years imprisonment, substantial fines, and was ordered to pay restitution to affected patients.
Significance:
Demonstrated severe criminal consequences in the US for counterfeit drug production.
Showed that intent to deceive and endanger human life is a key factor in prosecution.
4. Novartis AG vs. Jagdish & Ors., 2013 (India)
Court: Delhi High Court
Key Issue: Counterfeit life-saving drugs
Facts:
Jagdish and co-conspirators were producing fake Novartis-branded oncology drugs in Delhi. Investigation revealed fraudulent labeling, poor-quality ingredients, and illegal distribution channels.
Court Decision:
Court invoked IPC Sections 420 (cheating), 273 (adulteration of drugs), 272 (sale of adulterated drugs), 269 & 270 (negligent and malignant acts likely to spread disease), and provisions of the Drugs and Cosmetics Act.
Defendants were sentenced to imprisonment and the seized counterfeit drugs were destroyed.
Significance:
Reinforced that counterfeiting life-saving drugs is a serious criminal offense.
Highlighted judicial concern for public health protection over commercial interests.
5. Johnson & Johnson v. Chhaya Pharmaceuticals, 2015 (India)
Court: Bombay High Court
Key Issue: Manufacturing counterfeit branded painkillers
Facts:
Chhaya Pharmaceuticals was found producing painkillers branded under Johnson & Johnson’s name with substandard active ingredients. Investigation revealed deliberate misrepresentation to profit from a trusted brand.
Court Decision:
Court held that the accused committed fraud and criminal adulteration under the Drugs and Cosmetics Act and IPC Sections 420, 272, 273.
Ordered conviction, fines, and destruction of counterfeit products, along with permanent banning of the facility from production.
Significance:
Emphasized brand reputation protection along with public safety.
Reinforced criminal liability for intentional counterfeit drug production.
Key Legal Principles from These Cases
IPC Sections 420, 272, 273, 269, 270: Apply for cheating, adulteration, and acts likely to spread disease.
Drugs and Cosmetics Act Violations: Manufacturing, selling, or distributing counterfeit/substandard drugs attracts criminal liability.
Intent Matters: Criminal liability arises when there is deliberate intent to deceive or endanger life.
Severe Punishments: Courts have consistently imposed imprisonment, fines, and confiscation/destruction of counterfeit drugs.
Public Health Priority: Courts emphasize protecting human life over commercial or financial interests.
RELATED Blog
comments